pharmaceutical investing FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
pharmaceutical investing Antares Receives FDA Approval of Xyosted (Testosterone Enanthate) Injection for Testosterone Replacement Therapy
FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals
pharmaceutical investing Antares Pharma Announces FDA Approval of Generic EpiPen Utilizing VIBEX Auto Injector
pharmaceutical investing EyeGate Announces FDA Approval of Two IDE Submissions for Ocular Bandage Gel
medical device investing Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Independent Review of Syntholene Facility Confirms World Class Proof-of-Performance, Supports Potential for Cost-Competitive Synthetic Aviation Fuel
QIMC Extends Natural Hydrogen and Helium Seismic Program Across the Temiscamingue Graben into Ontario with 26.8 km New Seismic Line
Independent Review of Syntholene Facility Confirms World Class Proof-of-Performance, Supports Potential for Cost-Competitive Synthetic Aviation Fuel
Edgewater Wireless Brings Growing Semiconductor Momentum and Dual-Use Innovation to Canada's Semiconductor Symposium 2026
